Demonstration and diagnostic significance of pro-gastrin-releasing peptide in medullary thyroid carcinoma

Oncology

Volumn 59, Issue 2, 2000, Pages 122-125

  Inaji, Hideo ^a   Komoike, Yoshifumi ^a   Motomura, Kazuyoshi ^a   Higashiyama, Masahiko ^a   Ohtsuru, Minoru ^b   Funai, Hiroko ^a   Kasugai, Tsutomu ^a   Koyama, Hiroki ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b Kobe Ekisaikai Hospital   (Japan)

Author keywords

Medullary thyroid carcinoma; Pro gastrin releasing peptide; Thyroid carcinoma

Indexed keywords

CALCITONIN; CARCINOEMBRYONIC ANTIGEN; PEPTIDE DERIVATIVE; PROGASTRIN; TUMOR MARKER;

ADULT; ARTICLE; CALCITONIN BLOOD LEVEL; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT CANCER; THYROID MEDULLARY CARCINOMA;

EID: 0033828230     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012148     Document Type: Article

References (22)

1. Melvin KEW: The paraneoplastic syndrome associated with carcinoma of the thyroid gland. Ann NY Acad Sci 1974;230:378-390.
2. Ishikawa H, Hamada S: Association of medullary carcinoma of the thyroid with carcinoembryonic antigen. Br J Cancer 1976;34:111-115.
3. Kameya T, Bessho T, Tsumuraya M, Yamaguchi K, Abe K, Shimosato Y, Yanaihara N: Production of gastrin releasing peptide by medullary carcinoma of the thyroid. Virchows Arch 1983;401:99-108.
4. Dockray GJ, Villant C, Walsh SH: The neuronal origin of bombesin-like immunoreactivity in the rat gastrointestinal tract. Neuroscience 1979;4:1561-1568.
5. Nagalla SR, Gibson BW, Tang D, Reeve JD Jr, Spindel ER: Gastrin-releasing peptide (GRP) is not mammalian bombesin: Identification and molecular cloning of a true amphibian GRP distinct from amphibian hombesin in Bambina orientalis. J Biol Chem 1992;267:6916-6922.
6. Yamaguchi K, Abe K, Kameya T, Adachi I, Taguchi S, Otsubo K, Yanaihara N: Production and molecular size heterogeneity of immunoreactive gastrin-releasing peptide in fetal and adult lungs and primary lung tumors. Cancer Res 1983;43:3932-3939.
7. Ghatei MA, Springall DR, Nicholl CG, Polak JM, Bloom SR: Gastrin-releasing peptide-like immunoreactivity in medullary thyroid carcinoma. Am J Clin Pathol 1985;84:581-586.
8. Takami H, Bessho T, Kameya T, Mimura T. Ito K, Abe O, Hosoda Y. Shikata J: Immunohistochemical study of medullary thyroid carcinoma: Relationship of clinical features to prognostic factors in 36 patients. World J Surg 1988;12:572-579.
9. Mansson B, Ahren B, Nobin A, Böttcher G, Sundler F: Calcitonin, calcitonin gene-related peptide, and gastrin-relcasing pcptide in familial thyroid medullary carcinoma. Surgery 1990; 107:182-186.
10. Modigliani E, Casanova S, Chayvialle JA, Bernard C, Franc B, Cohen R, Calmettes C: Immunoreactive gastrin-releasing peptide in medullary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:831-835.
11. Scopsi L, Sampictro G, Boracchi P, Pilotti S: A critical appraisal of the prognostic utility of four separate immunocytochemical markers (somatostatin, gastrin-releasing peptide, neuro-peptide Y, and opioid peptides) in sporadic medullary thyroid carcinoma. Appl Immuno-histochem 1997;5:23-28.
12. Sausville EA, Lehacq-Verheyden AM, Spindel ER, Cuttitta F, Gardar AF, Battey JF: Expression of the gastrin-releasing peptide gene in human small cell lung cancer. J Biol Chem 1986;261:2451-2457.
13. Miyake Y, Kodama T, Yamaguchi K: Pro-gastrin releasing peptide(31-98) is a specific tumor marker in patients with small cell lung carcinoma. Cancer Res 1994;54:2136-2140.
14. Aoyagi K, Miyake Y, Urakami K, Kashiwakuma T, Hasegawa A, Kodama T, Yamaguchi K: Enzyme immunoassay for immunoreactive pro-gastrin-releasing peptide(31-98) as tumor marker for small-cell lung carcinoma: Development and evaluation. Clin Chem 1995;41:537-543.
15. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.
16. Kodama T, Abe S, Yamaguchi K, Eguchi K, Saigenji K, Kameya T, Kamata K, Miyake Y, Ariyoshi H, Ikeda S, Fukuoka M, Takada M, Kawahara M, Kimura I, lguchi H, Adachi N: Clinical significance for diagnosis of serum proGRP by enzyme-linked immunosorbent assay (ELISA) (in Japanese). Igaku To Yakugaku 1994;32:87-97.
17. Kamata K, Uchida M, Takeuchi Y, Takahashi E, Sato N, Miyake Y, Okubo M, Kodama T, Yamaguchi K: Increased serum concentrations of pro-gastrin-releasing peptide in patients with renal dysfunction. Nephrol Dial Transplant 1996;11-1267-1270.
18. Goto K, Kodama T, Hojo F, Kubota K, Kakinuma R, Matsumoto T, Ohmatsu H, Sekine I, Nagai K, Nishiwaki Y: Clinicopathologic characteristics of patients with nonsmall cell lung carcinoma with elevated serum progastrin-releasing peptide levels. Cancer 1998;82:1056-1061.
19. Yanagawa H, Shimada K, Tanaka H, Takeuchi E, Maniwa K, Suzuki Y, Ogushi F, Sano N, Izumi K, Sone S: A case with small cell carcinoma of the esophagus: Measurement of tumor markers, including pro-gastrin-releasing peptide. Anticancer Res 1998;18:2877-2880.
20. Shijubo N, Yamaguchi K, Hirasawa M, Shibuya Y, Inuzuka M, Kodama T, Abe S: Progastrin-releasing peptide(31-98)in idiopathic pulmonary fibrosis and sarcoidosis. Am J Respir Crit Care Med 1996;154:1694-1699.
21. Takada M, Kusunoki Y, Masuda N, Matui K, Yana T, Ushijima S, Iida K, Tamura K, Komiya T, Kawase I, Kikui N, Morino H, Fukuoka M: Pro-gastrin-releasing peptide(31-98) as a tumour marker of small-cell lung cancer: Comparative evaluation with neuron-specific enolase. Br J Cancer 1996;73:1227-1232.
22. Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD: Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 1985:316:823-826.